Abstract
The lung is a very attractive target for drug delivery. Currently, as direct access for the treatment of lower respiratory diseases. Possibly, in the future, as the route of administration for systemic therapies. Nebulizers are widely used throughout the world in adult and padiatric medical practice. They are used for the management of acute bronchoconstriction both at home and in hospital, but also for long-term home treatment of various lower respiratory diseases, mainly in elderly and in infants. Overall, bronchodilators are the first class of drugs used by nebulization. The efficiency of the nebulizer has to be assured mainly for suspension, such as corticosteroids, and hyperviscous solution, such as antimicrobials, which aerolize with more difficulties with respect to bronchodilators. Unfortunately, knowledge on the optimal use of nebulizers is limited. Guidelines on best nebulizer practice are often lacking. There is a need to establish some guidance for both the drug and nebulizer manufacturers and prescribing physicians for optimization of nebulizer therapy, individuating not only drugs, dosing and administration schedule, but also the effective nebulizer system and the method for its optimal use and maintenance.
Keywords: Aerosol therapy, nebulizer, inhalation therapy, COPD, asthma
Current Respiratory Medicine Reviews
Title: Nebulizer Therapy in Pulmonology: Review of the Literature
Volume: 2 Issue: 2
Author(s): Andrea S. Melani and Letizia S. Bracci
Affiliation:
Keywords: Aerosol therapy, nebulizer, inhalation therapy, COPD, asthma
Abstract: The lung is a very attractive target for drug delivery. Currently, as direct access for the treatment of lower respiratory diseases. Possibly, in the future, as the route of administration for systemic therapies. Nebulizers are widely used throughout the world in adult and padiatric medical practice. They are used for the management of acute bronchoconstriction both at home and in hospital, but also for long-term home treatment of various lower respiratory diseases, mainly in elderly and in infants. Overall, bronchodilators are the first class of drugs used by nebulization. The efficiency of the nebulizer has to be assured mainly for suspension, such as corticosteroids, and hyperviscous solution, such as antimicrobials, which aerolize with more difficulties with respect to bronchodilators. Unfortunately, knowledge on the optimal use of nebulizers is limited. Guidelines on best nebulizer practice are often lacking. There is a need to establish some guidance for both the drug and nebulizer manufacturers and prescribing physicians for optimization of nebulizer therapy, individuating not only drugs, dosing and administration schedule, but also the effective nebulizer system and the method for its optimal use and maintenance.
Export Options
About this article
Cite this article as:
Melani S. Andrea and Bracci S. Letizia, Nebulizer Therapy in Pulmonology: Review of the Literature, Current Respiratory Medicine Reviews 2006; 2(2) . https://dx.doi.org/10.2174/157339806776843067
DOI https://dx.doi.org/10.2174/157339806776843067 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Biomarkers in Post-stroke Depression
Current Neurovascular Research Beneficiary and Adverse Effects of Phytoestrogens: A Potential Constituent of Plant-based Diet
Current Pharmaceutical Design Effects of the Natural Isoflavonoid Genistein on Growth, Signaling Pathways and Gene Expression of Matrix Macromolecules by Breast Cancer Cells
Mini-Reviews in Medicinal Chemistry Breast Cancer Chemoprevention: Current Perspectives
Current Enzyme Inhibition Novel Concepts in the Pathogenesis and Management of Pediatric Hypertension
Current Pediatric Reviews Exercise-Induced Modulation of Endothelial Nitric Oxide Production
Current Pharmaceutical Biotechnology Anti-Inflammatory Therapeutic Approaches to Reduce Acute Atherosclerotic Complications
Current Pharmaceutical Biotechnology Approaches and Recent Trends in Gene Delivery for Treatment of Atherosclerosis
Recent Patents on Drug Delivery & Formulation Antioxidants Suppress Th1-Type Immune Response In Vitro
Drug Metabolism Letters Cardiac Cell Therapy and Bypass Surgery
Current Pharmaceutical Design Homeobox Genes and Human Genetic Disorders
Current Molecular Medicine Retraction Notice: Emerging Targets for COPD Therapy
Current Drug Targets - Inflammation & Allergy Nutlin-3, A p53-Mdm2 Antagonist for Nasopharyngeal Carcinoma Treatment
Mini-Reviews in Medicinal Chemistry High-Density Lipoprotein at the Interface of Type 2 Diabetes Mellitus And Cardiovascular Disorders
Current Pharmaceutical Design Influenza and Stroke Risk: A Key Target Not to be Missed?
Infectious Disorders - Drug Targets Growing Burden of Diabetes in Sub- Saharan Africa: Contribution of Pesticides ?
Current Diabetes Reviews Niemann-Pick C1-Like 1 (NPC1L1) Inhibition and Cardiovascular Diseases
Current Medicinal Chemistry Liver Enzymes: Potential Cardiovascular Risk Markers?
Current Pharmaceutical Design In Vitro Drug Release Behavior, Mechanism and Antimicrobial Activity of Rifampicin Loaded Low Molecular Weight PLGA-PEG-PLGA Triblock Copolymeric Nanospheres
Current Drug Delivery The Role of Chymase in Vascular Remodeling and Tissue Fibrosis
Current Hypertension Reviews